Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA District Office meeting

This article was originally published in The Gray Sheet

Executive Summary

Scheduled for July 17 in New Orleans to discuss "good clinical practices in investigational product research." Topics to be discussed are requirements for conducting investigational research and "practical issues," including how to prepare for a data audit and what to expect during an investigation. The meeting is formatted for open dialogue between FDA and individuals involved in investigational product research. First priority for attendance will be given to individuals located in Louisiana and Mississippi. Call Rebecca Asente at 504/589-6344, ext. 158, for additional information...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel